“…p38γ MAPK has been shown to regulate cell cycle transition, cell mobility, metastasis, EMT, CSC population, and tumorigenesis ( 10 , 36 – 39 ). Importantly, p38γ MAPK is overexpressed and implicated in several types of cancers including colorectal cancer, liver cancer, pancreatic cancer, and breast cancer ( 16 , 37 , 40 , 41 ); increased p38γ MAPK expression predicts a poor clinical prognosis ( 18 , 36 ). CSCs are a subpopulation of tumor cells capable of self-renewal and differentiation and involved in tumor initiation, recurrence, progression, chemoresistance and metastasis ( 38 ).…”